Pfizer stock price remains at $28

Pfizer stock price remains at $28.49, with traders closely watching 50-day moving average crossovers. Institutional flows indicate portfolio rebalancing toward healthcare in response to recent geopolitical developments. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. On the other hand, BofA maintained its Neutral rating on JNJ stock, as its analyst, Tim Anderson , believes that Trump’s deal with Pfizer was “pretty benign overall.” He explained that while the timing of the arrangement was unexpected, its substance was not disruptive. The company’s pipeline announcements in oncology are drawing speculative interest, with technical traders watching for a breakout above its current weekly highs.